Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | UGT2B7 | P16662 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL233611 | 0.85 | MGAM (0.40) | MGAMGAASIMGAM2EPHX2 | |
| SCHEMBL19436038 | 0.85 | MGAM (0.40) | MGAMGAASIMGAM2EPHX2 | |
| SCHEMBL3867901 | 0.85 | MGAM (0.40) | MGAMGAASIMGAM2EPHX2 | |
| SCHEMBL12332966 | 0.85 | MGAM (0.40) | MGAMGAASIMGAM2EPHX2 | |
| SCHEMBL3871745 | 0.85 | MGAM (0.40) | MGAMGAASIMGAM2EPHX2 | |
| SCHEMBL28020726 | 0.83 | MGAM (0.36) | MGAMGAASIMGAM2EPHX2 | |
| SCHEMBL25293694 | 0.82 | LMNA (0.32) | LMNABLMCYP2D6KMT2A | |
| SCHEMBL25293630 | 0.79 | CYP2D6 (0.31) | CYP2D6 | |
| SCHEMBL30175181 | 0.78 | LMNA (0.31) | LMNABLMCYP2D6 | |
| SCHEMBL31547087 | 0.76 | L3MBTL1 (0.39) | GAAEPHX2UGT2B7ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230202963-A1 | ESTERS AS FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2023-06-29 | — | — | US | disclosed |
| US-20230202963-A1 | ESTERS AS FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2023-06-29 | — | — | US | disclosed |
| US-20230202963-A1 | ESTERS AS FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230202963-A1 | ESTERS AS FRAGRANCE COMPOUNDS | CUTA, TRPA1, FASN | MGAM 3672/4885GAA 3084/4885SI 958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.